GDTC
CYTOMED THERAPEUTICS LIMITED

303
Mkt Cap
$16.31M
Volume
24,143.00
52W High
$3.68
52W Low
$1.29
PE Ratio
-5.66
GDTC Fundamentals
Price
$1.36
Prev Close
$1.39
Open
$1.42
50D MA
$1.82
Beta
0.00
Avg. Volume
40,557.64
EPS (Annual)
-$0.1632
P/B
2.80
Rev/Employee
$1,209.44
Loading...
Loading...
News
all
press releases
News Placeholder
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge PR Newswire VANCOUVER, BC, Oct. 15, 2025 Equity Insider News...
PR Newswire·3mo ago
News Placeholder
Why Did CytoMed Therapeutics Stock Jump 19% Today?
The company said that the proposed acquisition of TC BioPharm will strengthen and deepen its expertise and knowledge in using allogeneic cell therapies for cancer treatment.
Stocktwits·3mo ago
<
...
1
>

Latest GDTC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.